Hepatocellular carcinoma immunopathogenesis: Clinical evidence for global T cell defects and an immunomodulatory role for soluble CD25 (sCD25)

Digestive Diseases and Sciences

Volumn 55, Issue 2, 2010, Pages 484-495

  Cabrera, Roniel ^a   Ararat, Miguel ^a   Cao, Mengde ^a   Xu, Yiling ^a   Wasserfall, Clive ^a   Atkinson, Mark A ^a   Liu, Chen ^a   Nelson, David R ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

IL 2 signaling; Liver cancer; Serum; Soluble factors; Soluble IL 2 receptor alpha chain (sIL 2RA); T cell immunosuppression; Tumor tolerance

Indexed keywords

ADENOSINE TRIPHOSPHATE; GAMMA INTERFERON; INTERLEUKIN 2 RECEPTOR ALPHA; IL2RA PROTEIN, HUMAN; TUMOR MARKER;

ADULT; AGED; APOPTOSIS; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE PRODUCTION; EFFECTOR CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME LINKED IMMUNOSPOT ASSAY; FEMALE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOMODULATION; IMMUNOPATHOGENESIS; LIVER CELL CARCINOMA; LYMPHOCYTE FUNCTION; LYMPHOCYTE PROLIFERATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; BLOOD; CELL PROLIFERATION; CELLULAR IMMUNITY; COMPARATIVE STUDY; FLOW CYTOMETRY; IMMUNOLOGY; LIVER TUMOR; MIDDLE AGED; PATHOLOGY; T LYMPHOCYTE; TUMOR CELL CULTURE;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; CELL PROLIFERATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNITY, CELLULAR; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; LIVER NEOPLASMS; MALE; MIDDLE AGED; T-LYMPHOCYTES; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL;

EID: 76849085439     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-009-0955-5     Document Type: Article

References (25)

1. DM Parkin F Bray J Ferlay, et al. 2001 Estimating the world cancer burden: Globocan 2000 Int J Cancer 94 153 156 10.1002/ijc.1440 1:CAS:528:DC%2BD3MXntVGlu78%3D 11668491 (Pubitemid 32911406)
2. HB El-Serag JA Davila NJ Petersen KA McGlynn 2003 The continuing increase in the incidence of hepatocellular carcinoma in the United States: an update Ann Intern Med 139 817 823 14623619
3. G Fattovich G Giustina F Degos, et al. 1997 Morbidity and mortality in compensated cirrhosis type C: a retrospective follow-up study of 384 patients Gastroenterology 112 463 472 10.1053/gast.1997.v112.pm9024300 1:STN:280:DyaK2s7ns1Olsw%3D%3D 9024300 (Pubitemid 27078833)
4. JM Llovet A Burroughs J Bruix 2003 Hepatocellular carcinoma Lancet 362 1907 1917 10.1016/S0140-6736(03)14964-1 14667750 (Pubitemid 37518510)
5. JM Llovet S Ricci V Mazzaferro P Hilgard E Gane JF Blanc, et al. 2008 Sorafenib in advanced hepatocellular carcinoma N Engl J Med 359 378 390 10.1056/NEJMoa0708857 1:CAS:528:DC%2BD1cXovFWjsL8%3D 18650514
6. P Newell A Villanueva JM Llovet 2008 Molecular targeted therapies in hepatocellular carcinoma: from pre-clinical models to clinical trials J Hepatol 49 1 5 10.1016/j.jhep.2008.04.006 1:CAS:528:DC%2BD1cXmvFelsr0%3D 18486262
7. M Kalos 2003 Tumor antigen-specific T cells and cancer immunotherapy: current issues and future prospects Vaccine 21 781 786 10.1016/S0264-410X(02) 00598-4 1:CAS:528:DC%2BD3sXjtFKlsg%3D%3D 12531359 (Pubitemid 36091997)
8. Y Wada O Nakashima R Kutami O Yamamoto M Kojiro 1998 Clinicopathological study on hepatocellular carcinoma with lymphocytic infiltration Hepatology 27 407 414 10.1002/hep.510270214 1:STN:280:DyaK1c7it1Cksg%3D%3D 9462638 (Pubitemid 28081054)
9. M Cao R Cabrera Y Xu R Firpi H Zhu C Liu, et al. 2007 Hepatocellular carcinoma cell supernatants increase expansion and function of CD4+CD25+ regulatory T cells Lab Invest 87 582 590 1:CAS:528:DC%2BD2sXltlejsb4%3D 17372588
10. LA Ormandy T Hillemann H Wedemeyer, et al. 2005 Increased populations of regulatory T cells in peripheral blood of patients with hepatocellular carcinoma Cancer Res 65 6 2457 2464 10.1158/0008-5472.CAN-04-3232 1:CAS:528: DC%2BD2MXisFGnsL0%3D 15781662 (Pubitemid 40490158)
11. E Unitt SM Rushbrook A Marshall, et al. 2005 Compromised lymphocytes infiltrate hepatocellular carcinoma: the role of T-regulatory cells Hepatology 41 722 730 10.1002/hep.20644 1:CAS:528:DC%2BD2MXjsV2ms7c%3D 15791620 (Pubitemid 40462933)
12. J Fu D Xu Z Liu M Shi P Zhao B Fu, et al. 2007 Increased regulatory T cells correlate with CD8 T-cell impairment and poor survival in hepatocellular carcinoma patients Gastroenterology 132 2328 2339 10.1053/j.gastro.2007.03.102 17570208 (Pubitemid 46890865)
13. J Bruix M Sherman 2005 Practice guidelines committee, American association for the study of liver diseases. Management of hepatocellular carcinoma Hepatology 42 1208 1236 10.1002/hep.20933 16250051 (Pubitemid 43112690)
14. DR Nelson Z Tu C Soldevila-Pico M Abdelmalek H Zhu YL Xu R Cabrera, et al. 2003 Hepatology 38 859 868 1:CAS:528:DC%2BD3sXovFGhtb0%3D 14512873
15. R Cabrera M Ararat C Soldevila-Pico L Dixon JJ Pan R Firpi, et al. 2009 Using an immune functional assay to differentiate acute cellular rejection from recurrent hepatitis C in liver transplant patients Liver Transpl 15 216 222 10.1002/lt.21666 19177434
16. B Hoechst LA Ormandy M Ballmaier F Lehner C Krüger MP Manns, et al. 2008 A new population of myeloid-derived suppressor cells in hepatocellular carcinoma patients induces CD4+CD25+Foxp3+ T cells Gastroenterology 135 234 243 10.1053/j.gastro.2008.03.020 1:CAS:528:DC%2BD1cXps1Wltb0%3D 18485901 (Pubitemid 351899008)
17. S Murakami 2004 Soluble IL-2 receptor in cancer Front Biosci 1 9 3085 3090 10.2741/1461
18. LM Maier DE Anderson CA Severson C Baecher-Allan B Healy DV Liu, et al. 2009 Soluble IL-2RA levels in multiple sclerosis subjects and the effect of soluble IL-2RA on immune responses J Immunol 182 1541 1547 1:CAS:528: DC%2BD1MXnsVeqsw%3D%3D 19155502
19. RK Chopra DC Powers NE Kendig WH Adler JE Nagel 1989 Soluble interleukin 2 receptors released from mitogen stimulated human peripheral blood lymphocytes bind interleukin 2 and inhibit IL2 dependent cell proliferation Immunol Invest 18 961 973 10.3109/08820138909045783 1:CAS:528:DyaK3cXltlCrsQ%3D%3D 2583751
20. LA Rubin G Jay DL Nelson 1986 The released interleukin 2 receptor binds interleukin 2 efficiently J Immunol 137 12 3841 3844 1:CAS:528: DyaL2sXkvVCgsw%3D%3D 3023487
21. SJ Levine 2004 Mechanisms of soluble cytokine receptor generation J Immunol 173 5343 5348 1:CAS:528:DC%2BD2cXos1Gitbg%3D 15494479
22. C Becker MC Fantini C Schramm HA Lehr S Wirtz A Nikolaev, et al. 2004 TGF-beta suppresses tumor progression in colon cancer by inhibition of IL-6 trans-signaling Immunity 21 491 501 10.1016/j.immuni.2004.07.020 1:CAS:528:DC%2BD2cXpvVygt7c%3D 15485627 (Pubitemid 39370505)
23. L Giannitrapani M Cervello M Soresi M Notarbartolo M La Rosa L Virruso, et al. 2002 Circulating IL-6 and sIL-6R in patients with hepatocellular carcinoma Ann N Y Acad Sci 963 46 52 1:CAS:528:DC%2BD38XlvVOjurc%3D 12095927
24. E Bien A Balcerska 2008 Serum soluble IL-2 receptor alpha in human cancer of adults and children: a review Biomarkers 13 1 26 10.1080/13547500701674063 1:CAS:528:DC%2BD1cXksVKktA%3D%3D 17906988
25. MS von Bergwelt-Baildon A Popov T Saric J Chemnitz S Classen MS Stoffel, et al. 2006 CD25 and indoleamine 2, 3-dioxygenase are up-regulated by prostaglandin E2 and expressed by tumor-associated dendritic cells in vivo: additional mechanisms of T-cell inhibition Blood 108 228 237 10.1182/blood-2005-08-3507 (Pubitemid 43990633)